Search research articles
Contact Us
Filters
Showing results (201-210 of 265) with videos related to
Page
of 27
Sort By:
The British Journal of Dermatology
|
December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
Jan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
European Heart Journal
|
August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
Lars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
Frontiers in Immunology
|
March 3, 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
Jan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, et al.
Cancers
|
September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
Anne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Langenbeck'S Archives of Surgery
|
July 10, 2023
Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline "Adult Soft Tissue Sarcomas"
Jens Jakob, Dimosthenis Andreou, Jens Bedke, et al.
Cancer Immunology, Immunotherapy : CII
|
October 28, 2021
Clinical determinants of long-term survival in metastatic uveal melanoma
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 12, 2024
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
Ines Pires da Silva, Isabel Li, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2025
Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024
Philippe Saiag, Celeste Lebbe, Lieve Brochez, et al.
Cancers
|
June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
Georg Lodde, Andrea Forschner, Jessica Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Page
of 27
Search research articles
Search
Showing results (201-210 of 265) with videos related to
Sort By:
Page
of 27
The British Journal of Dermatology
|
December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
Jan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
European Heart Journal
|
August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
Lars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
Frontiers in Immunology
|
March 3, 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
Jan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, et al.
Cancers
|
September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
Anne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Langenbeck'S Archives of Surgery
|
July 10, 2023
Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline "Adult Soft Tissue Sarcomas"
Jens Jakob, Dimosthenis Andreou, Jens Bedke, et al.
Cancer Immunology, Immunotherapy : CII
|
October 28, 2021
Clinical determinants of long-term survival in metastatic uveal melanoma
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 12, 2024
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases
Ines Pires da Silva, Isabel Li, Selma Ugurel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2025
Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024
Philippe Saiag, Celeste Lebbe, Lieve Brochez, et al.
Cancers
|
June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients
Georg Lodde, Andrea Forschner, Jessica Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Page
of 27